查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人工授精市場規模、佔有率和成長分析（按類型、來源類型、最終用途、地區）：產業預測（2024-2031）
市場調查報告書
商品編碼
1593513

人工授精市場規模、佔有率和成長分析（按類型、來源類型、最終用途、地區）：產業預測（2024-2031）

Artificial Insemination Market Size, Share, Growth Analysis, By Type (Intrauterine, Intravaginal), By Source Type (AIH-Husband, AID-Donor), By End Use (Fertility Clinics, Other Facilities), By Region -Industry Forecast 2024-2031.
出版日期: | 出版商: SkyQuest | 英文 159 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球人工授精市場規模估值為21億美元，從2023年的22億美元擴大到2031年的38億美元，預計在預測期內（2024-2031年）複合年成長率為8.01%。

由於不孕率上升和對人工授精技術的需求不斷增加，輔助生殖技術市場正經歷顯著成長。這種快速成長主要是由於生活方式的改變以及子宮內膜異位症和卵巢綜合症（PCOS）等醫療狀況的流行，這些疾病需要先進的生殖解決方案。此外，新興國家對人工授精的接受度不斷提高也支持了市場的擴張。改進的精子和卵子選擇方法、冷凍保存技術和胚胎著床前基因檢測等技術進步也在推動成長。此外，同性婚姻合法化、更廣泛地接受 LGBTQ+ 父母身份以及捐贈精子和卵子等社會變化也在推動該行業向前發展。不孕症政策、意識和教育措施正在推動這一成長軌跡，同時對個人化治療方案的需求不斷增加。促進市場動態的其他因素包括生殖醫學保險覆蓋範圍的擴大、由於職業偏好而推遲生育的趨勢以及提供人工授精服務的診所和醫療機構的激增。總而言之，這些因素代表了一個強勁且不斷發展的市場環境，對於尋求輔助生殖技術的多元化人群來說，該環境變得更加包容和可及。

目錄

介紹

  • 分析目的
  • 定義
  • 市場範圍

分析方法

  • 資訊採購
  • 二手資料來源和主要資料來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況及展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制因素和挑戰
  • 波特分析及影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 技術進步
  • 監管環境
  • 專利分析
  • 價值鏈分析
  • PESTEL分析
  • 宏觀經濟指標
  • 貿易分析

全球人工授精市場規模（按類型）/複合年成長率（2024-2031）

  • 子宮腔內人工授精
  • 子宮頸內人工授精
  • 陰道內人工授精
  • 輸卵管內授精

全球人工授精市場規模（依來源類型）/複合年成長率（2024-2031）

  • 配偶間人工授精（AIH）
  • 非婚人工授精（AID）

全球人工授精市場規模（依最終用戶）/複合年成長率（2024-2031）

  • 生育治療診所和其他設施
  • 在家裡

全球人工授精市場規模（按地區）/複合年成長率（2024-2031）

  • 北美（按類型、來源、最終用戶）
    • 美國
    • 加拿大
  • 歐洲（按類型、來源、最終用戶）
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家
  • 亞太地區（依類型、來源、最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲（按類型、來源、最終用戶）
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲（按類型、來源、最終用戶）
    • 波灣合作理事會(GCC) 國家
    • 南非
    • 其他中東/非洲

競爭資訊

  • 前5名企業對比
  • 主要企業市場定位（2023年）
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析（2023）
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 按細分市場分類的佔有率分析
    • 收益年增率比較（YoY）（2021-2023）

主要企業簡介

  • Genea Pty Limited
  • Vitrolife
  • Rinovum Women's Health, LLC
  • Pride Angel
  • HI-TECH SOLUTIONS
  • FUJIFILM Irvine Scientific
  • Kitazato Corporation
  • Rocket Medical plc
  • Conceivex, Inc.
  • Genea Limited
  • Genus plc.
  • Zoetis Inc.
  • ABS Global
  • Hamilton Thorne Inc.
  • Continental Genetics
  • Select Series
  • Neogen Corporations
  • Agtech inc
  • Imv Technologies
  • TenderNeeds Fertility LLC

結論和建議

簡介目錄
Product Code: SQMIG35A2961

Global Artificial Insemination Market size was valued at USD 2.1 billion in 2022 and is poised to grow from USD 2.2 billion in 2023 to USD 3.8 billion by 2031, growing at a CAGR of 8.01% during the forecast period (2024-2031).

The market for assisted reproductive technologies is experiencing significant growth, driven by a rise in infertility rates and an increasing demand for artificial insemination techniques. This surge is largely attributed to lifestyle changes and the prevalence of medical conditions such as endometriosis and polycystic ovary syndrome (PCOS), necessitating advanced reproductive solutions. Additionally, the growing acceptance of artificial insemination in developing countries further supports market expansion. Technological advancements like improved sperm and egg selection methods, cryopreservation techniques, and pre-implantation genetic testing are also fueling growth. Furthermore, societal changes, including the legalization of same-sex marriage and broader acceptance of LGBTQ+ parenthood, alongside the availability of donor sperm and eggs, are propelling the industry forward. Enabling policies, increased awareness, and educational initiatives regarding artificial insemination and infertility are contributing to this growth trajectory, along with a heightened demand for personalized treatment options. Other factors enhancing market dynamics include expanding insurance coverage for reproductive procedures, a trend toward delayed childbearing favoring professional aspirations, and the proliferation of clinics and medical institutions offering artificial insemination services. Collectively, these elements indicate a robust and evolving market landscape that is becoming more inclusive and accessible to a diverse range of individuals seeking reproductive assistance.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Insemination market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Insemination Market Segmental Analysis

The Global Artificial Insemination Market is segmented into Type, Source Type, End Use, and Region. Based on Type, the market is segmented into Intrauterine, Intracervical, Intravaginal, and Intratubal. Based on Source Type, the market is segmented into AIH-Husband and AID-Donor. Based on End Use, it is segmented into Fertility Clinics & Other Facilities, and Home. Based on Region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Artificial Insemination Market

The rising infertility rates globally serve as a significant market driver for the Global Artificial Insemination market. As couples and individuals struggle with delayed conception due to changing lifestyles, environmental factors, and an increase in reproductive health disorders, the demand for assisted reproductive technologies has surged. Artificial insemination emerges as a vital solution for those unable to conceive naturally, fostering greater acceptance and awareness of fertility treatments. Furthermore, an increasing societal interest in advanced reproductive methods strengthens the market's growth potential, as more individuals actively seek out artificial insemination to achieve their reproductive aspirations. This trend solidifies its status as a necessity in modern reproductive healthcare.

Restraints in the Global Artificial Insemination Market

The global artificial insemination market faces significant restraint due to the high costs associated with treatment, which often surpasses the financial capacity of many individuals and couples, particularly in lower-income demographics. The expenses associated with multiple treatment cycles, medications, and supplementary medical procedures can be prohibitive, especially in regions with inadequate insurance coverage for infertility treatments. This financial barrier limits access to artificial insemination, creating disparities in reproductive healthcare access. To address this issue and broaden the market's reach, it is essential to implement strategies aimed at reducing costs and enhancing affordability, thus making these services accessible to a wider population.

Market Trends of the Global Artificial Insemination Market

The Global Artificial Insemination market is witnessing a significant trend driven by the increasing utilization of advanced reproductive technologies. Innovations in genetic screening, cryopreservation, and high-tech sperm processing techniques have enhanced conception rates while minimizing invasiveness. Notable advancements include preimplantation genetic testing, which screens embryos for genetic disorders, thereby offering couples greater confidence in their reproductive choices. Additionally, improvements in sperm freezing and thawing methods provide patients with more flexible options. This technological evolution aims to personalize treatment protocols and boost success rates, ultimately broadening the market's growth and meeting the rising demand for effective reproductive solutions worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Trade Analysis

Global Artificial Insemination Market Size by Type & CAGR (2024-2031)

  • Intrauterine Insemination
  • Intracervical Insemination
  • Intravaginal Insemination
  • Intratubal Insemination

Global Artificial Insemination Market Size by Source Type & CAGR (2024-2031)

  • AIH-Husband
  • AID-Donor

Global Artificial Insemination Market Size by End User & CAGR (2024-2031)

  • Fertility clinics & other facilities
  • Home

Global Artificial Insemination Market Size by Region & CAGR (2024-2031)

  • North America, (Type, Source, End User)
    • US
    • Canada
  • Europe, (Type, Source, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Type, Source, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Type, Source, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Type, Source, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Genea Pty Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rinovum Women's Health, LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pride Angel
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HI-TECH SOLUTIONS
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Irvine Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kitazato Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rocket Medical plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Conceivex, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genus plc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ABS Global
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Thorne Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Continental Genetics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Select Series
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neogen Corporations
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agtech inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Imv Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TenderNeeds Fertility LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation